170 related articles for article (PubMed ID: 15128428)
1. Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia.
Zver S; Andoljsek D; Cernelc P
Eur J Haematol; 2004 Jun; 72(6):455-6. PubMed ID: 15128428
[No Abstract] [Full Text] [Related]
2. Use of Novoseven for arsenic trioxide-induced bleeding in PML.
Alimoghaddam K; Ghavamzadeh A; Jahani M
Am J Hematol; 2006 Sep; 81(9):720. PubMed ID: 16804937
[No Abstract] [Full Text] [Related]
3. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
[TBL] [Abstract][Full Text] [Related]
4. Immediate haemostasis with recombinant factor VIIa for haemorrhage following Hickman line insertion in acute myeloid leukaemia.
Osborne W; Bhandari S; Tait RC; Franklin IM
Clin Lab Haematol; 2004 Jun; 26(3):229-31. PubMed ID: 15163323
[TBL] [Abstract][Full Text] [Related]
5. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
[TBL] [Abstract][Full Text] [Related]
6. The use of recombinant factor VIIa in a patient with essential thrombocythaemia with uncontrolled surgical bleeding.
Cervera JS; Mena-Durán AV; Piqueras CS
Thromb Haemost; 2005 Feb; 93(2):383-4. PubMed ID: 15711760
[No Abstract] [Full Text] [Related]
7. Successful use of recombinant activated factor VII in controlling upper gastrointestinal bleeding in a patient with relapsed acute myeloid leukemia.
Hoffman R; Eliakim R; Zuckerman T; Rowe JM; Brenner B
J Thromb Haemost; 2003 Mar; 1(3):606-8. PubMed ID: 12871480
[No Abstract] [Full Text] [Related]
8. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
Shamsi T; Tufail M; Aftab M; Ansari S
J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
[TBL] [Abstract][Full Text] [Related]
9. The use of recombinant factor VIIa for bleeding in paediatric practice.
Millar CG; Stringer MD; Sugarman I; Richards M
Haemophilia; 2005 Mar; 11(2):171-4. PubMed ID: 15810920
[TBL] [Abstract][Full Text] [Related]
10. The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
Udy A; Vaghela M; Lawton G; Sigston P
Anaesthesia; 2005 Jun; 60(6):613-6. PubMed ID: 15918835
[TBL] [Abstract][Full Text] [Related]
11. Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
Guerin V; Chossat I; Dutronc H; Dubreuil M; Valentin F
Am J Hematol; 2002 Aug; 70(4):333. PubMed ID: 12210820
[No Abstract] [Full Text] [Related]
12. Recombinant activated factor VII (NovoSeven) stops severe intra-abdominal bleeding after liver needle biopsy without surgery.
Sendensky A; Gutzwiller JP; Schneider-Frost J; Wuillemin WA; Graeni R; Beglinger C
Blood Coagul Fibrinolysis; 2004 Oct; 15(8):701-2. PubMed ID: 15613927
[No Abstract] [Full Text] [Related]
13. [Administration of activated recombinant factor VII (novo seven) for the control of massive bleeding in gynecology].
Tanchev S; Pandurski F; Georgiev A; Gesheva Iu; Platikanov V; Dinov P
Akush Ginekol (Sofiia); 2004; 43 Suppl 2():32-5. PubMed ID: 15518274
[TBL] [Abstract][Full Text] [Related]
14. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
Manning BJ; Hynes N; Courtney DF; Sultan S
Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):525-7. PubMed ID: 16099693
[TBL] [Abstract][Full Text] [Related]
15. Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent.
Dunkley SM; Mackie F
Hematology; 2003 Aug; 8(4):263-4. PubMed ID: 12911945
[TBL] [Abstract][Full Text] [Related]
16. Successful use of recombinant factor VIIa in pelvic fracture haemorrhage.
Dhruva KK; Joel VD; Antony S; Vinodan K
J Indian Med Assoc; 2006 Jan; 104(1):42, 44. PubMed ID: 16850866
[TBL] [Abstract][Full Text] [Related]
17. Management of bleeding using recombinant factor VIIa in a patient suffering from bleeding tendency due to a lupus anticoagulant-hypoprothrombinemia syndrome.
Holm M; Andreasen R; Ingerslev J
Thromb Haemost; 1999 Dec; 82(6):1776-8. PubMed ID: 10613675
[No Abstract] [Full Text] [Related]
18. [Recombinant factor VII activated in non-hemophiliac patients with acute severe hemorrhage in the intensive care unit].
Carrillo-Esper R; Sánchez-Zúñiga Mde J; Elizondo-Argueta S; Visoso-Palacios P; Carrillo-Córdova JR
Gac Med Mex; 2006; 142(5):369-76. PubMed ID: 17128815
[TBL] [Abstract][Full Text] [Related]
19. Recombinant activated factor VII: a new weapon in the fight against hemorrhage.
Branch DW; Rodgers GM
Obstet Gynecol; 2003 Jun; 101(6):1155-6. PubMed ID: 12798515
[No Abstract] [Full Text] [Related]
20. Recombinant activated factor VII treatment of retroperitoneal hematoma in a patient with renal failure receiving enoxaparin and clopidogrel.
Cherfan A; Arabi Y; Al Askar A; Al Shimemeri A
Pharmacotherapy; 2007 May; 27(5):755-9. PubMed ID: 17461711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
